Orion Portfolio Solutions LLC bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,724 shares of the company’s stock, valued at approximately $115,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. NEXT Financial Group Inc raised its stake in Henry Schein by 67.3% during the fourth quarter. NEXT Financial Group Inc now owns 378 shares of the company’s stock valued at $25,000 after buying an additional 152 shares during the last quarter. Cullen Frost Bankers Inc. grew its holdings in Henry Schein by 153.1% during the fourth quarter. Cullen Frost Bankers Inc. now owns 496 shares of the company’s stock valued at $33,000 after purchasing an additional 300 shares during the period. Parallel Advisors LLC grew its holdings in Henry Schein by 50.3% during the fourth quarter. Parallel Advisors LLC now owns 923 shares of the company’s stock valued at $61,000 after purchasing an additional 309 shares during the period. Meeder Asset Management Inc. grew its holdings in Henry Schein by 33.2% during the fourth quarter. Meeder Asset Management Inc. now owns 1,123 shares of the company’s stock valued at $75,000 after purchasing an additional 280 shares during the period. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its holdings in Henry Schein by 167.0% during the fourth quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 1,335 shares of the company’s stock valued at $89,000 after purchasing an additional 835 shares during the period.

Several brokerages have recently commented on HSIC. JPMorgan Chase & Co. boosted their price objective on Henry Schein from $66.00 to $68.00 and gave the company a “neutral” rating in a research report on Monday, February 24th. Evercore ISI cut Henry Schein from an “in-line” rating to an “underperform” rating in a research note on Friday, January 3rd. Bank of America cut Henry Schein from a “neutral” rating to an “underperform” rating and set a $65.00 target price on the stock. in a research note on Thursday, January 9th. BidaskClub cut Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, ValuEngine cut Henry Schein from a “sell” rating to a “strong sell” rating in a research note on Monday, February 10th. Five research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $70.67.

Henry Schein stock traded up $3.05 during mid-day trading on Wednesday, reaching $50.03. 3,306,795 shares of the company were exchanged, compared to its average volume of 1,601,505. The business has a fifty day moving average of $61.89 and a 200 day moving average of $65.15. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 1.58. The firm has a market cap of $6.19 billion, a P/E ratio of 10.67, a PEG ratio of 1.57 and a beta of 0.92. Henry Schein, Inc. has a 12-month low of $41.85 and a 12-month high of $73.99.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.91 by $0.06. Henry Schein had a return on equity of 15.01% and a net margin of 6.96%. The firm had revenue of $2.67 billion during the quarter, compared to analyst estimates of $2.64 billion. During the same quarter in the prior year, the business posted $1.12 EPS. The business’s revenue for the quarter was up 7.9% compared to the same quarter last year. Sell-side analysts predict that Henry Schein, Inc. will post 3.67 EPS for the current year.

In related news, Vice Chairman James P. Breslawski sold 6,636 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $61.32, for a total value of $406,919.52. Following the completion of the transaction, the insider now owns 265,282 shares in the company, valued at approximately $16,267,092.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.06% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: Price to Earnings Ratio (PE) Basics

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.